To BE or Not to BE: Non-invasive Screening for Barrett's Esophagus, Dysplasia and Adenocarcinoma

Overview

Journal Transl Gastroenterol Hepatol

Publisher AME Publishing Company

Specialty Gastroenterology

Date 2019 Jun 25

PMID 31231698

Citations 1

Authors

Alok K Shah

Virendra Joshi

Gunter Hartel

Andrew P Barbour

Michelle M Hill

Affiliations

Soon will be listed here.

Citing Articles

The evolution of endoscopic therapy for Barrett's esophagus.

Condon A, Muthusamy V Ther Adv Gastrointest Endosc. 2021; 14:26317745211051834.

PMID: 34708204 PMC: 8543722. DOI: 10.1177/26317745211051834.

References

Jobe B, Hunter J, Chang E, Kim C, Eisen G, Robinson J . Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol. 2007; 101(12):2693-703. DOI: 10.1111/j.1572-0241.2006.00890.x. View

Ramirez F, Akins R, Shaukat M . Screening of Barrett's esophagus with string-capsule endoscopy: a prospective blinded study of 100 consecutive patients using histology as the criterion standard. Gastrointest Endosc. 2008; 68(1):25-31. DOI: 10.1016/j.gie.2007.10.040. View

Bhardwaj A, Hollenbeak C, Pooran N, Mathew A . A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2009; 104(6):1533-9. DOI: 10.1038/ajg.2009.86. View

Gora M, Sauk J, Carruth R, Gallagher K, Suter M, Nishioka N . Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med. 2013; 19(2):238-40. PMC: 3567218. DOI: 10.1038/nm.3052. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Whiteman D, Appleyard M, Bahin F, Bobryshev Y, Bourke M, Brown I . Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2015; 30(5):804-20. DOI: 10.1111/jgh.12913. View

Ross-Innes C, Debiram-Beecham I, ODonovan M, Walker E, Varghese S, Lao-Sirieix P . Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study. PLoS Med. 2015; 12(1):e1001780. PMC: 4310596. DOI: 10.1371/journal.pmed.1001780. View

Vaughan T, Fitzgerald R . Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2015; 12(4):243-8. PMC: 4382373. DOI: 10.1038/nrgastro.2015.24. View

El-Serag H, Naik A, Duan Z, Shakhatreh M, Helm A, Pathak A . Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus. Gut. 2015; 65(8):1252-60. DOI: 10.1136/gutjnl-2014-308865. View

10.

Shaheen N, Falk G, Iyer P, Gerson L . ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2015; 111(1):30-50. PMC: 10245082. DOI: 10.1038/ajg.2015.322. View

11.

Chan D, Zakko L, Visrodia K, Leggett C, Lutzke L, Clemens M . Breath Testing for Barrett's Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device. Gastroenterology. 2016; 152(1):24-26. DOI: 10.1053/j.gastro.2016.11.001. View

12.

Ross-Innes C, Chettouh H, Achilleos A, Galeano-Dalmau N, Debiram-Beecham I, MacRae S . Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol Hepatol. 2017; 2(1):23-31. DOI: 10.1016/S2468-1253(16)30118-2. View

13.

Chettouh H, Mowforth O, Galeano-Dalmau N, Bezawada N, Ross-Innes C, MacRae S . Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens. Gut. 2017; 67(11):1942-1949. PMC: 6176521. DOI: 10.1136/gutjnl-2017-314026. View

14.

Moinova H, LaFramboise T, Lutterbaugh J, Chandar A, Dumot J, Faulx A . Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus. Sci Transl Med. 2018; 10(424). PMC: 5789768. DOI: 10.1126/scitranslmed.aao5848. View

15.

Spechler S, Katzka D, Fitzgerald R . New Screening Techniques in Barrett's Esophagus: Great Ideas or Great Practice?. Gastroenterology. 2018; 154(6):1594-1601. DOI: 10.1053/j.gastro.2018.03.031. View

16.

Thrift A . Barrett's Esophagus and Esophageal Adenocarcinoma: How Common Are They Really?. Dig Dis Sci. 2018; 63(8):1988-1996. DOI: 10.1007/s10620-018-5068-6. View

17.

Iyer P, Taylor W, Johnson M, Lansing R, Maixner K, Yab T . Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus. Am J Gastroenterol. 2018; 113(8):1156-1166. DOI: 10.1038/s41395-018-0107-7. View

18.

Sami S, Iyer P, Pophali P, Halland M, di Pietro M, Ortiz-Fernandez-Sordo J . Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening. Clin Gastroenterol Hepatol. 2018; 17(4):638-646.e1. PMC: 6330075. DOI: 10.1016/j.cgh.2018.07.019. View

19.

Shah A, Hartel G, Brown I, Winterford C, Na R, Le Cao K . Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus. Mol Cell Proteomics. 2018; 17(12):2324-2334. PMC: 6283291. DOI: 10.1074/mcp.RA118.000734. View

20.

Pavlov K, Kluiver J, Meijer C, Boersma-van Ek W, Kruyt F, Karrenbeld A . Circulating miRNAs in patients with Barrett's esophagus, high-grade dysplasia and esophageal adenocarcinoma. J Gastrointest Oncol. 2019; 9(6):1150-1156. PMC: 6286950. DOI: 10.21037/jgo.2018.08.01. View